Added value of sGC stimulator in worsening HFrEF patients - PACE-CME

Added value of sGC stimulator in worsening HFrEF patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Use of ARNI in HFpEF patients reduces NT-proBNP levels
Use of ARNI in HFpEF patients reduces NT-proBNP levels
ACC 2020
Use of ARNI in HFpEF patients reduces NT-proBNP levels
- Jonathan Cunningham, MD
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
ACC 2020
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
- Prof. George Dangas, MD, PhD
Mechanistic underpinning of CV benefit observed with icosapent ethyl
Mechanistic underpinning of CV benefit observed with icosapent ethyl
ACC 2020
Mechanistic underpinning of CV benefit observed with icosapent ethyl
- Deepak Bhatt, MD
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
ACC 2020
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
- Prof. Frederick Raal